NYSE:ELAN

Elanco Animal Health (ELAN) Stock Price, News & Analysis

Elanco Animal Health logo
$26.32 -0.38 (-1.44%)
Closing price 11/19/2026 03:59 PM Eastern
Extended Trading
$26.05 -0.26 (-1.00%)
As of 08:31 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Elanco Animal Health Stock (NYSE:ELAN)

Advanced

Key Stats

Today's Range
$26.29
▼
$27.49
50-Day Range
$21.78
▼
$26.82
52-Week Range
$19.40
▼
$27.98
Volume
7.05 million shs
Average Volume
5.43 million shs
Market Capitalization
$13.15 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.36
Consensus Rating
Moderate Buy

Company Overview

Elanco Animal Health is a global animal health company that develops, manufactures and markets products for companion animals and livestock. Its offerings include medicines, vaccines and other products intended to prevent and treat disease and support animal health.

For pets, Elanco provides treatments for conditions including parasitic infections, pain and chronic diseases. Its livestock products support the health of animals such as cattle, poultry, swine and fish, serving producers and veterinarians.

The company traces its origins to Eli Lilly’s animal health business, established in 1954, and became an independent public company in 2018. Elanco serves customers in markets around the world and expanded its portfolio through the acquisition of Bayer Animal Health in 2020.

AI Generated. May Contain Errors.

Elanco Animal Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

ELAN MarketRank™: 
2.84613267272 of 5 stars

Elanco Animal Health scored higher than 57% of companies evaluated by MarketBeat, and ranked 382nd out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Elanco Animal Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 9 buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    Elanco Animal Health has a consensus price target of $30.36, representing about 15.4% upside from its current price of $26.32.

  • Amount of Analyst Coverage

    Elanco Animal Health has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Elanco Animal Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Elanco Animal Health are expected to grow by 9.32% in the coming year, from $1.18 to $1.29 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Elanco Animal Health is -87.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Elanco Animal Health is -87.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Elanco Animal Health has a PEG Ratio of 2.26. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Elanco Animal Health has a P/B Ratio of 1.98. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    6.67% of the float of Elanco Animal Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Elanco Animal Health has a short interest ratio ("days to cover") of 7.18.
  • Change versus previous month

    Short interest in Elanco Animal Health has recently increased by 5.84%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Elanco Animal Health does not currently pay a dividend.

  • Dividend Growth

    Elanco Animal Health does not have a long track record of dividend growth.

  • News Sentiment

    Elanco Animal Health has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for Elanco Animal Health this week, compared to 5 articles on an average week.
  • Search Interest

    Only 2 people have searched for ELAN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Elanco Animal Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $835,950.00 in company stock, which represents 0.0064% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Elanco Animal Health insiders have bought 835.53% more of their company's stock than they have sold. Specifically, they have bought $936,000.00 in company stock and sold $100,050.00 in company stock.

  • Percentage Held by Insiders

    1.14% of the stock of Elanco Animal Health is held by insiders.

  • Percentage Held by Institutions

    97.48% of the stock of Elanco Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Elanco Animal Health's insider trading history.
Receive ELAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elanco Animal Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ELAN Stock News Headlines

Under 3 cents a night
Bill Poulos's Black Friday deal: a full year of the Instant Scanner for $7, one payment. The regular price is $247, about a dollar a night. With roughly 250 trading nights a year, that's 2.8 cents a night to have nearly a thousand of America's biggest stocks checked, with exact buy prices on whatever qualifies. No re-bills and nothing to install. At $7, the only question is whether you get around to it.tc pixel
Elanco to Participate in Upcoming Investor Conferences
See More Headlines

ELAN Stock Analysis - Frequently Asked Questions

Elanco Animal Health's stock was trading at $22.64 on January 1st, 2026. Since then, ELAN shares have increased by 16.2% and is now trading at $26.3160.

Elanco Animal Health Incorporated (NYSE:ELAN) announced its earnings results on Friday, November, 6th. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.07. Elanco Animal Health's revenue was up 11.3% compared to the same quarter last year.
Read the conference call transcript
.

Elanco Animal Health's board approved a stock repurchase plan on Thursday, November 19th 2026, which authorizes the company to buy back $600 million in outstanding shares, according to EventVestor. This means that the company could buy up to 4.5% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's leadership believes its shares are undervalued.

Elanco Animal Health (ELAN) raised $1.4 billion in an initial public offering (IPO) on Thursday, September 20th 2018. The company issued 62,900,000 shares at $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Barclays, BNP PARIBAS, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Evercore ISI, Cowen, Academy Securities, Drexel Hamilton, Mischler Financial Group, Ramirez and The Williams Capital Group were co-managers.

Top institutional shareholders of Elanco Animal Health include Dodge & Cox (12.29%), State Street Corp (3.26%), Marshall Wace LLP (2.01%) and Artemis Investment Management LLP (0.92%). Insiders that own company stock include Lawrence Erik Kurzius, R David Hoover, Jeffrey N Simmons, Rajeev A Modi, Timothy J Bettington, Robert M Vanhimbergen, Michael J Harrington, Paul Herendeen and Shiv O'neill.
View institutional ownership trends
.

Shares of ELAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Elanco Animal Health investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Salesforce (CRM), Pfizer (PFE), Merck & Co., Inc. (MRK), Palo Alto Networks (PANW) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
11/06/2026
Today
11/20/2026
9th Annual Evercore ISI HealthCONx Conference
11/30/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NYSE:ELAN
CIK
1739104
Fax
N/A
Employees
9,400
Year Founded
1954

Price Target and Rating

High Price Target
$35.00
Low Price Target
$24.00
Potential Upside/Downside
+15.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.30)
Trailing P/E Ratio
N/A
Forward P/E Ratio
20.40
P/E Growth
2.26
Net Income
-$232 million
Net Margins
-2.86%
Pretax Margin
-1.79%
Return on Equity
8.80%
Return on Assets
4.32%

Debt

Debt-to-Equity Ratio
0.55
Current Ratio
2.09
Quick Ratio
1.07

Sales & Book Value

Annual Sales
$4.72 billion
Price / Sales
2.79
Cash Flow
$2.29 per share
Price / Cash Flow
11.51
Book Value
$13.26 per share
Price / Book
1.98

Miscellaneous

Outstanding Shares
499,830,000
Free Float
494,129,000
Market Cap
$13.15 billion
Optionable
Optionable
Beta
1.73

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

This page (NYSE:ELAN) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners